An integrative systems genetics approach reveals potential causal genes and pathways related to obesity by Kogelman, Lisette et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
An integrative systems genetics approach reveals potential causal genes and
pathways related to obesity
Kogelman, Lisette; Zhernakova, Daria V.; Westra, Harm-Jan; Cirera Salicio, Susanna;
Fredholm, Merete; Franke, Lude; Kadarmideen, Haja
Published in:
Genome Medicine
DOI:
10.1186/s13073-015-0229-0
Publication date:
2015
Document version
Publisher's PDF, also known as Version of record
Citation for published version (APA):
Kogelman, L., Zhernakova, D. V., Westra, H-J., Cirera Salicio, S., Fredholm, M., Franke, L., & Kadarmideen, H.
(2015). An integrative systems genetics approach reveals potential causal genes and pathways related to
obesity. Genome Medicine, 7, [105]. https://doi.org/10.1186/s13073-015-0229-0
Download date: 03. Feb. 2020
RESEARCH Open Access
An integrative systems genetics approach
reveals potential causal genes and
pathways related to obesity
Lisette J. A. Kogelman1, Daria V. Zhernakova2, Harm-Jan Westra3,4,5, Susanna Cirera1, Merete Fredholm1,
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Abstract
Background: Obesity is a multi-factorial health problem in which genetic factors play an important role. Limited
results have been obtained in single-gene studies using either genomic or transcriptomic data. RNA sequencing
technology has shown its potential in gaining accurate knowledge about the transcriptome, and may reveal novel
genes affecting complex diseases. Integration of genomic and transcriptomic variation (expression quantitative trait
loci [eQTL] mapping) has identified causal variants that affect complex diseases. We integrated transcriptomic data
from adipose tissue and genomic data from a porcine model to investigate the mechanisms involved in obesity
using a systems genetics approach.
Methods: Using a selective gene expression profiling approach, we selected 36 animals based on a previously created
genomic Obesity Index for RNA sequencing of subcutaneous adipose tissue. Differential expression analysis was
performed using the Obesity Index as a continuous variable in a linear model. eQTL mapping was then performed to
integrate 60 K porcine SNP chip data with the RNA sequencing data. Results were restricted based on genome-wide
significant single nucleotide polymorphisms, detected differentially expressed genes, and previously detected
co-expressed gene modules. Further data integration was performed by detecting co-expression patterns
among eQTLs and integration with protein data.
Results: Differential expression analysis of RNA sequencing data revealed 458 differentially expressed genes. The
eQTL mapping resulted in 987 cis-eQTLs and 73 trans-eQTLs (false discovery rate < 0.05), of which the cis-eQTLs were
associated with metabolic pathways. We reduced the eQTL search space by focusing on differentially expressed and
co-expressed genes and disease-associated single nucleotide polymorphisms to detect obesity-related genes and
pathways. Building a co-expression network using eQTLs resulted in the detection of a module strongly associated
with lipid pathways. Furthermore, we detected several obesity candidate genes, for example, ENPP1, CTSL, and
ABHD12B.
Conclusions: To our knowledge, this is the first study to perform an integrated genomics and transcriptomics (eQTL)
study using, and modeling, genomic and subcutaneous adipose tissue RNA sequencing data on obesity in a porcine
model. We detected several pathways and potential causal genes for obesity. Further validation and investigation
may reveal their exact function and association with obesity.
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Background
Obesity is characterized by an excessive amount of body
adipose tissue. Because adipose tissue has many endo-
crine functions, obesity is a very complex condition and
is associated with several severe diseases, such as type 2
diabetes, metabolic syndrome, and several types of can-
cer. The prevalence of obesity is exponentially rising
world-wide [1] and its enormous consequences for the
quality of life and life expectancy have led to the need
for a better understanding of the molecular pathology in-
volved. To date, genome-wide association studies (GWAS)
have identified many different loci associated with obesity
and obesity-related phenotypes [2, 3]. However, they ex-
plain a limited amount of the 40–70 % predicted genetic
variation [2] and provide limited insight into the biological
pathways and molecular mechanisms involved.
Transcriptomic analysis can further elucidate the mo-
lecular mechanisms, because gene expression provides a
link between genetic variations and their correspond-
ing phenotypic alterations [4]. Commonly, transcriptomic
data are used to gain biological insight by detecting differ-
ences in expression levels [5] between two conditions
(i.e., healthy and diseased). Many studies have applied
differential expression (DE) analysis to obesity using
different tissues, and have detected many biologically
relevant genes [6–10]. However, all these studies have
used a microarray or quantitative polymerase chain reac-
tion (qPCR) platform. High-throughput RNA sequencing
(RNA-Seq) technology has demonstrated advantages be-
yond microarray technology [11]: the transcriptome is
measured more fully and RNA-Seq facilitates the discov-
ery of novel genes. In DE analysis, RNA-Seq data outper-
form microarray data in terms of the accuracy of
measuring gene expression levels and, therefore, RNA-Seq
can potentially detect more differentially expressed (DE)
genes [12].
Systems genetics approaches via the integration, joint
modeling, and analyses of various high-throughput -omics
data that represent different levels of biological orga-
nization are becoming more popular in genetic studies
[13–15]. The integration of genomic and transcriptomic
data can be achieved using expression quantitative trait
loci (eQTL) studies, whereby genetic variants that under-
pin differences in expression levels are mapped [14, 16]. It
has been shown that eQTLs are highly heritable [17, 18]
and have the potential to provide more biological insight
into GWAS findings [16]. Several studies have investi-
gated obesity and obesity-related diseases using an
eQTL approach, but mainly using microarray expres-
sion data [19–21]. Moreover, integration of these data
with those from other publically available databases,
such as those containing protein–protein interactions
(PPI), might also provide further insight into the bio-
logical mechanisms behind complex diseases [22, 23].
Here, we present the analysis of RNA-Seq data from
subcutaneous adipose tissue from a porcine model spe-
cifically created to study obesity. The pig has similar
metabolic, physiological, and genetic features to humans,
with greater similarity than rodents have to humans, and
has shown great potential as a medical model [24, 25].
Extensive discussions on why pigs are a better model are
given in our paper describing the pig resource popula-
tion [26]. We previously showed that the F2 population
created for obesity studies demonstrates a high heritabil-
ity for obesity-related phenotypes [26] and we have de-
tected several obesity-related genes and pathways using
network approaches on the genotype [27] and RNA-Seq
data [28]. Furthermore, we previously created the Obesity
Index (OI), an aggregate additive genetic value for obesity,
by combining nine different obesity-related phenotypes
[27]. Based on a selective expression profiling design, we
selected 36 animals in three groups (lean, intermediate,
and obese) for RNA-Seq, and showed that those animals
have different metabolic features [28]. In this study, we
performed an integrative systems genetics approach to
identify causal genes and associated pathways for obesity.
This was achieved by integrating information on genetic
variants from GWAS (based on high-throughput genotype
data) with information from co-expression networks (based
on RNA-Seq data) and differential gene expression (based
on RNA-Seq data), using an eQTL mapping approach
[29, 30]. We also integrated biologically interesting
co-expression modules with the known PPI networks
to identify key transcriptional and other protein-coding
factors underlying the causation of obesity. Thus, the
integration of multi-omic biological datasets led to the
detection of several obesity-related genes and molecular
pathways.
Methods
The pig population
The animal resource used in this study was established
using breeds that diverged with respect to obesity traits
in the parental generation, resulting in a F2 population
that was highly divergent with respect to obesity and
obesity-related traits. All F2 animals were fed and housed
equally. Animal care and maintenance have been con-
ducted according to the Danish “Animal Maintenance
Act” (Act 432 dated 09/06/2004) and biological samples
were collected according to the Danish “Veterinary Proce-
dures Act” (Act 433 dated 09/06/2004). For a detailed
description of the pedigree and the phenotypes, see [26].
In this study, we only used the animals from the Duroc ×
Göttingen minipig intercross, which has been previously
described [28]. In short, 279 F2 animals resulting from an
intercross between the G ttingen minipig (predisposed
for obesity) and Duroc production pig (selected for lean
meat content) were intensively phenotyped (e.g., weight,
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conformation traits, dual-energy X-ray absorptiometry
(DXA) scanning, and slaughter characteristics) and geno-
typed using the Illumina 60 K porcine SNP chip. We
previously created and described the OI [27]—a response
variable that is an aggregate genotypic value representing
the degree of obesity based on the selection index theory
[31]. The OI follows a normal distribution; therefore,
animals for RNA-Seq of the subcutaneous adipose tissue
were selected using a selective gene expression profiling
approach [32, 33]. This approach was carefully chosen to
ensure sufficient power to detect eQTLs with a relatively
small number of animals. In total, we selected 36 animals
across three groups: 12 lean, 12 intermediate, and 12
obese animals (Table 1). The family structure (maximizing
the number of full siblings to three) and sex distribution
was taken into account in the selection of the animals.
RNA sequencing
RNA-Seq was performed as previously described [28]. In
short, total RNA was isolated from porcine subcutaneous
adipose tissue using the RNeasy Lipid Tissue Mini kit
(Qiagen, Hilden, Germany) following the manufacturer’s
recommendations. The RNA quantity and quality were
assessed by a Nanodrop ND-1000 spectrophotometer and
the integrity of the isolated RNA was visually inspected by
gel electrophoresis and by measuring the RNA quality in-
dicator value on an Experion system (BioRad, Hemel
Heampstead, UK) using the Eukaryote Total RNA StdSens
kit (BioRad). Libraries were subsequently constructed
using 400 ng total RNA and a TruSeq RNA Sample Prep
(Illumina, San Diego, CA, USA) with Poly-A pull down
rRNA depletion, following the manufacturer’s recom-
mendations. Samples were sequenced on the
HiSeq2500 platform, by dividing the 36 samples over
four lanes and using 100 bp paired-end reads. Before
alignment, the quality of the reads was checked and the
adapters were detected using FastQC. The reads were
mapped to the genome assembly SScrofa10.2.72 in STAR
aligner using default parameters [34], whereby detected
adapters were removed. On average, 20,390 protein-
coding genes were detected among the mapped reads.
Read counts were estimated using HTSeq [35]. Because
transcripts with extremely low expression levels are less
reliable [36], transcripts with expression levels equal to or
fewer than five counts were removed from the dataset,
resulting in 12,253 transcripts per sample. The between-
sample bias was removed by estimating the library size
factor using the estimateSizeFactor() function in DESeq
[37]. Normalization was then performed using the voom()
variance-stabilization function in the R-package Limma
[38], and samples were corrected for sex and transformed
to log2-counts per million to approach normality.
Association of gene expression with degree of obesity
DE genes were detected using a linear model in the
R-package Limma [38], taking into account OI as a con-
tinuous variable and sex as a factor. First, a linear model
was fitted for each gene using the function lmFit() in
Limma:
yij ¼ βj;OIOIi þ βj;sexsexi þ εij
where yij is the measured expression level of gene j for
individual i, βj,OI is the estimated regression coefficient
from regressing the gene expression value of the ith indi-
vidual in its Obesity Index (OIi) for the j
th gene, βj,sex is
the estimated regression coefficient of sex, and εij is the
error component. Genes were called as DE when the
βj,OIwas significantly different from 0. Moderated t-
statistics (ratio of the log2-fold change to its standard
error) and log-odds of differential expression by em-
pirical Bayes moderation of the standard errors towards a
common value were then calculated using the function
eBayes() in Limma. While moderated t-test statistics
account for differences in the variance of gene expression
of a gene across replicates, the log-odds represents the
odds of a gene being DE with an OI different from 0. The
resulting P-values obtained from the moderated t-statistic
were corrected for multiple testing using the Benjamini-
Hochberg procedure [39]. Genes were identified as DE
when the adjusted P-value false discovery rate [FDR])
was below 0.05. The corresponding gene symbols were
reported using BioMart [40].
eQTL mapping
The integration of the SNP genotype and RNA-Seq data
was obtained using an eQTL study approach [13, 29], fol-
lowing the method as described in Westra et al. [30]. The
raw expression data obtained by RNA-Seq were quantile-
normalized, log2-normalized, and centered around zero
on a gene level. Finally, a z-transformation was performed
Table 1 Phenotypic characteristics of selected animals
Group Number of males Number of females Number of unique grandsires Obesity index
Mean Standard deviation
Lean 7 5 6 −2.47 0.75
Intermediate 6 6 8 0.07 0.11
Obese 6 6 4 2.4 0.36
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on the sample level. Genes were excluded when their
expression was below five read counts for any of the
samples, because lowly expressed genes potentially intro-
duce a bias. Furthermore, previous studies have shown
that the first expression principal components capture
experimental variation such as technical and batch effects
[41]. Therefore, several eQTL studies were performed on
the complete dataset with different principal components
removed. In total, four principal components were re-
moved, because this resulted in the highest number of
detected eQTLs. The SNPs were included in the genotype
data when they had a call rate above 0.95, a minor allele
frequency (MAF) above 0.05, and were in Hardy–
Weinberg equilibrium (P > 1E−4). The SNPs were mapped
onto the genome using genome assembly SScrofa10.2.74.
Both cis- and trans-eQTL mapping were performed:
eQTLs were considered to be cis-acting when the distance
between the gene and SNP was less than 1 Mb, and trans-
acting when the distance was greater than 1 Mb or when
the eQTL was located on another chromosome. The rela-
tively large flanking distance of 1 Mb was chosen because
haplotype blocks in pigs are larger than in humans and
are even larger in F2 populations. Other eQTL pig
studies have adapted an even larger flanking distance
(e.g., 10 Mb) for assigning cis-eQTLs [19, 42]. To correct
for multiple testing, we created a null distribution of
P-values by permuting expression phenotypes relative
to genotypes ten times, and then compared the real eQTL
P-value distribution to the null distribution. eQTLs were
only considered to be significant if the FDR was below
0.05. If several eQTLs were detected per gene, the stron-
gest effect for each gene was presented.
The eQTL mapping was first performed on all SNPs
and genes that exceeded the quality control thresholds
(52,004 SNPs and 12,253 genes). Furthermore, the ana-
lyses were restricted to genes that were DE in this study
(458 genes) and to SNPs that were significantly associ-
ated with the OI, according to our previously published
analysis (366 SNPs) [27].
The detected eQTLs were further investigated accord-
ing to their physical location in the genome and their
effects. The distance from the expression SNP (eSNP) to
the affected gene was calculated as the distance from the
location of the SNP to the location of the transcription
start site of the affected gene. The location and the effect
of the eSNPs were assigned using the Variant Effect Pre-
dictor [43] with the SScrofa10.2.74 assembly, where the
results were restricted to the most severe annotation of
the SNP variant.
Integration of eQTLs with co-expression network analysis
We previously conducted a weighted gene co-expression
network analysis (WGCNA) on the same RNA-Seq data,
and recently published the method and results [28]. To
integrate the results from the previous study with those
of this study, we evaluated how many eQTLs in the
WGCNA modules (clusters of highly interconnected genes)
could be detected. We focused solely on the modules
that were previously detected as potential biologically
interesting: the Blue Module, the Brown Module, the
Light-yellow Module, the Black Module, and the Green-
yellow Module [28]. Because we are interested in potential
causal genes within these modules, we extracted only
those genes from the modules that were identified as cis-
eQTLs.
Supervised gene co-expression network analysis and the
integration of protein–protein interactions
All detected genes in the eQTL mapping and DE analysis
were used for supervised WGCNA (sWGCNA). The net-
work was constructed using the framework of Langfelder
and Horvath [44], which is also described in Kogelman et
al. [27]. Briefly, the adjacency matrix was created by
calculating the Pearson’s correlations between the selected
genes, and was raised by a power β to reach a scale-free
topology index (R2) of at least 0.90. The topological over-
lap measure (TOM), which assess the degree of shared
neighbors between pairs of genes, was calculated based on
the adjacency matrix and was used as input for the gene
dendrogram (1-TOM). Following this step, modules were
detected and assigned to a color as branches of the gene
dendrogram using the DynamicTreeCut algorithm [45],
using a minimum module size of 25 genes per module.
The module eigengene, the first principal component of
each module, represents the module’s expression and
was used to detect biologically relevant modules. The
Module–Trait Relationship (MTR) was calculated as the
correlation between the module eigengene and traits of
interest, and modules with a significant correlation >0.5
were selected for functional annotation. Genes in the
module were retained when their intra-modular con-
nectivity was >0.6, and when their intra-modular con-
nectivity with other modules was >0.6. The module hub
gene was detected as the gene in the module with the
highest connectivity, or based on a high intra-modular
connectivity (>0.8) and high correlation between the
individual gene and the trait of interest (>0.6).
Potentially relevant biological modules were visualized
in Cytoscape [46] and were integrated with the known PPI
from IntAct [47], where corresponding Uniprot accession
IDs were extracted using BioMart [40]. The networks of
the selected module and PPI were merged and network
analysis within Cytoscape was performed to gain insight
into the network topology. Subsequently, the community
clustering algorithm GLay [48] (in the ClusterMaker app)
was used to detect clusters in the merged co-expression
and PPI network.
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Functional annotation
Over-represented Gene Ontology (GO) terms and KEGG
pathways among the DE genes were detected using the
software GoSeq [49], because GoSeq corrects for length
bias in RNA-Seq data. First, a probability weighting func-
tion for all genes was calculated, based on a given set of
biased data for gene length with the function nullp() in
GoSeq. Second, a selection-unbiased testing was per-
formed for GO or KEGG enrichment amongst the DE
genes. The P-values were corrected for multiple testing
using the Benjamini-Hochberg method and GO terms
and KEGG pathways were detected as being signifi-
cantly over-represented using a P-value of 0.05. The
over-represented GO terms and KEGG pathways were
separately detected for all DE genes, including the up-
regulated and downregulated DE genes.
Functional annotation analysis of the detected eQTLs
was performed using GeneNetwork (http://www.gene
network.nl), which detects over-represented GO terms,
KEGG pathways, and associated phenotypes and tissues
[50]. GeneNetwork is based on expression datasets from
humans, mice, and rats, and predicts functions of genes
against known pathways in various biological databases.
The over-representation of GO terms and pathways was
tested using the Mann–Whitney U test, and P-values
were corrected for multiple testing using the Bonferroni
correction.
The complete workflow used in this study is presented
in Fig. 1.
Availability of supporting data
The RNA-Seq expression data in this publication have
been deposited in NCBI’s Gene Expression Omnibus
(GEO) and are available through accession number
[GEO:GSE61271].
Results and discussion
Association of gene expression with degree of obesity
The detection of DE genes can lead to a better under-
standing of genetic and biological differences between
two different conditions and to the detection of predict-
ive biomarkers [51, 52]. In this study, we have used the
level of obesity as a continuous variable, whereby we
correct for the effect of sex. In total, we found 458 DE
genes (FDR < 0.05), with a βj,OI ranging from −0.42 to
0.48. All DE results are presented in Additional file 1.
The heatmap of the top 100 DE genes (Fig. 2) shows
that mostly those from the lean and obese animals cluster
together within each group. However, those from inter-
mediate animals cluster with both the obese and lean
groups. This is possibly due to the OI values of the inter-
mediate group being borderline between the two groups.
The genes partly clustered based on the direction of
regulation (up or down). The top 10 DE genes include
TAS1R3, CSGALNACT1, MAML3, ROM1, LRRC16B,
EML5, RPS12 (all downregulated in obese animals), and
ADAM9 (upregulated in obese animals). We discuss here
only selected genes from this group. The TAS1R3 gene
encodes a taste receptor, which has been associated with
Fig. 1 Workflow of the analyses performed in this study. Circles represent previously published analyses; dashed lines represent the
integration of the analysis results. eQTL expression quantitative trait loci, eSNP expression single nucleotide polymorphism, PPI
protein–protein interaction
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sweetness responsiveness in mice [53]. Taste receptors
influence the perception of food [54], and therefore affect
eating behavior [55], which might be associated with obes-
ity [56, 57]. The CSGALNACT1 (chondroitin sulfate N-
acetylgalactosaminyltransferase 1) gene plays a role in the
process of glucuronidation: the addition of glucuronic acid
to a substrate. This gene has been associated with Bell’s
palsy (dysfunctioning of the facial nerve, resulting in facial
paralysis) and Morquio Syndrome b (a metabolic disease,
characterized by the inability to breakdown glycosamino-
glycans). However, this gene also has an important func-
tion in the development of osteoarthritis [58], a bone
remodeling disease that has been associated with obesity.
The 40S ribosomal protein S12 is encoded by RPS12,
which is associated with diabetic nephropathy in African
Americans [59]. The final gene, ADAM9, encodes a trans-
membrane glycoprotein that functions in integrin binding
and SH3 domain binding. The ADAM9 gene is involved
in the formation of multinuclear cells and, consequently,
with osteoclast fusion [60]; its downregulation might re-
sult in reduced bone mass. Bone mineral density is closely
related to obesity: it has been suggested that the increased
body load on joints resulting from obesity might stimulate
the formation of bone mass, even though data from stud-
ies remain controversial [61]. However, body adipose
tissue is also closely associated with the immune system
and bone remodeling (decreased bone mineral density), by
the secretion of adipocytes [62]. In a previous study, we
identified several genes that might play a role in these
associations [28]. The downregulation of these genes in
obese animals might correspond to the decreased bone
mass via the secretion of adipocytes, but does not corres-
pond to an increased obesity-induced bone mass.
Out of the 458 DE genes, 249 were downregulated and
209 were upregulated in obese animals. Functional an-
notation analysis was performed for the downregulated
and upregulated genes separately. Surprisingly, almost all
over-represented pathways were the result of the presence
of upregulated genes. The over-represented pathways
were mostly associated with the immune system (e.g.,
Ribosome, P = 4.54E−12 and leukocyte trans-endothelial
migration, P = 4.32E−4), except for starch and sucrose me-
tabolism (P = 6.67E−4) and osteoclast differentiation (P =
6.67E−4). However, osteoclasts are derived from macro-
phages and therefore are also related to the immune
system [63], which was shown previously [28]. Within
the GO terms, DE genes showed a striking relation-
ship, mainly among the upregulated genes, with the im-
mune system, (e.g., immune system process, P = 2.79E−20
and immune response, P = 7.92E−18). The downregulated
genes were mainly involved with functions related to
ribosomes and the translational process (e.g., translational
Fig. 2 Heatmap of the top 100 differentially expressed genes. The intensity of the yellow/red colors represents the expression level. The rows and
columns have been sorted according to the gene clustering tree. The left-hand bar is color-coded according to the upregulation or downregulation
in obese animals. The upper bars below the animal cluster represents the obesity status and the sex of the animals. DE differentially expressed
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termination, P = 6.56E−17 and cytosolic ribosome, P =
1.33E−15), which cannot be linked directly to obesity itself.
The location and annotation of eQTLs
The eQTL mapping led to the detection of 1,070 eQTLs:
987 cis-eQTLs and 73 trans-eQTLs (FDR < 0.05). All
detected eQTLs are presented in Additional file 2. SNPs
used for eQTL mapping were filtered based on a high
MAF (<0.05). To ensure that this did not affect results
owing to the low number of animals, we investigated the
MAF of the eSNPs. From those results (not presented),
it was evident that most SNPs that were detected as
eQTLs had a high MAF. More specifically, only 14 SNPs
of the detected eQTLs had a MAF between 0.05 and
0.10. Based on those results and the statistical models
used to estimate the eQTL effects, followed by appropri-
ate significance testing, we believe that the results are
reliable.
The detected eQTLs were annotated as cis when the
distance between the eSNP and gene was within 1 Mb.
This was confirmed by the results, which show that most
of the cis-eQTLs were located close to the transcription
start site, as expected, because this is the region where
most transcriptional regulation occurs (Fig. 3a). Further
investigation of the effect of the eQTLs (Fig. 3b) showed
that most were located in intergenic (46 %) and intronic
regions (37 %). In comparison with the complete set of
SNPs that passed quality control, we found that the
eQTLs were located more often in intronic regions (>8 %)
and less often in intergenic regions (<10 %); the frequen-
cies in all other regions were not altered. These percent-
ages agree with the results of previous studies, which
showed that disease-associated SNPs are mainly located
within non-coding regions (~90 %) [64–66]. We found
comparable frequencies of intergenic and intronic SNPs
between cis-eQTLs and trans-eQTLs, where SNPs from
cis-eQTLs were also located in exonic regions (3′ untrans-
lated region [UTR], 5′UTR, mis-sense, and splice regions).
These intergenic and intronic SNPs might be in linkage
disequilibrium with a causative SNP, but might also have a
regulatory function on the gene expression of the eQTL.
Of the detected trans-eQTLs, 10 SNPs were located on a
different chromosome than the target gene. We further
investigated the distance between the SNP and target
gene of the trans-eQTLs that were located on a similar
chromosome, and found that a large part of the trans-
eQTL would be detected as cis by increasing the window
size by several megabases (Fig. 4a). Furthermore, we inves-
tigated the number of target genes per detected trans-
eQTL and found that most SNPs were targeting up to five
genes (Fig. 4b).
Functional annotation of eQTLs
Functional annotation analysis using all detected cis-
eQTLs (987) revealed many metabolism-related GO terms
and pathways (Table 2). We also found that several adi-
pose tissues (e.g., adipocytes and subcutaneous adipose
tissue) were highly significantly associated with the cis-
eQTLs.
In order to identify potential causal genes, we limited
the number of eQTL association tests by confining the
eQTL mapping to DE genes (458 genes) and, secondly,
to obesity-associated SNPs resulting from the previously
conducted GWAS on the OI (366 SNPs) [27]. Using
the restriction of DE genes, we found a total of 36
eQTLs, among which GO terms and pathways related
Fig. 3 a Histogram depicting the distance from the expression single nucleotide polymorphism (eSNP) to the affected transcript of all cis-expression
quantitative trait loci, with the transcription start site as a base (distance = 0 kb). b Visualization of the variant effects of the eSNPs (both cis and trans)
as a percentage. Kb kilobase, UTR untranslated region
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to cholesterol transport and other lipid process were
represented, for example, protein–lipid complex (P =
2E−4), and lipid digestion, mobilization, and transport
(P = 2E−5). Restriction to GWAS SNPs resulted in the
detection of 24 eQTLs. Functional annotation showed
that these genes were mainly expressed in adipose tissue
(subcutaneous fat, abdominal; P = 4E−3) and associated phe-
notypes also showed a link with obesity-related characteris-
tics (e.g., abnormal triglyceride level, P = 1E−3). Other GO
terms and pathways were related to transcription (e.g.,
viral transcription, P = 3E−4), metabolism (tyrosine me-
tabolism, P = 1E−3), or immunity (e.g., influenza infection,
P = 2E−4). Of those 24 eQTLs, the expression of one target
gene was significantly associated (P < 0.05) with the
OI: C15orf26. However, this gene does not seem to
have any previously discovered association with obesity or
obesity-related diseases. Two other genes tended toward
significance: RAB11A and USP36 (P < 0.1) RAB11A has
been shown to be an element in the GLUT4 trafficking
machinery [67] and has been associated with glucose me-
tabolism [68]. To our knowledge, USP36 has not been
previously associated with obesity or obesity-related dis-
eases. Unfortunately, we did not identify any overlap of
eQTLs between the restricted analyses of the DE subset
and GWAS subset.
From the 36 eQTLs detected among the subset of DE
genes, 35 were also present in the eQTLs using no re-
strictions. One of these eQTLs involves the ENPP1
(ectonucleotide pyrophosphatase/phosphodiesterase 1)
gene (Fig. 5a) that encodes a type II transmembrane glyco-
protein (P = 1.43E−4). This glycoprotein plays a role in the
regulation of pyrophosphate levels, and several other func-
tions are known: for example, bone mineralization and the
regulation of purinergic signaling. More importantly, this
gene is highly expressed in adipose tissue and has been
associated with obesity, type-2 diabetes, and insulin resist-
ance [69, 70] and also with eating behavior in a pig popu-
lation [57]. Moreover, expression of this gene inhibits
insulin signaling via reduced insulin-receptor tyrosine kin-
ase activity [71]. The data here showed a large difference
between the AA and GG phenotypes, whereby the AA
animals were lean and GG animals (with an increased
expression of ENPP1) were obese, which agrees with data
in the literature. For example, the AA animals (n = 8)
a b
Fig. 4 Visualization of the detected trans-expression quantitative trait loci (e-QTLs). a The distance between the single nucleotide polymorphism
and target gene of the trans-eQTLs. b The number of target genes per trans-eQTL
Table 2 GeneNetwork results over all cis-eQTLs
Pathway or process P-value
GO: BP co-factor biosynthetic process 1 × 10−18
co-factor metabolic process 6 × 10−18
water-soluble vitamin metabolic process 3 × 10−17
GO: CC mitochondrial matrix 5 × 10−13
organelle outer membrane 1 × 10−12
outer membrane 2 × 10−12
GO: MF transferase activity, transferring alkyl or aryl
(other than methyl) groups
2 × 10−17
co-enzyme binding 3 × 10−14
co-factor binding 3 × 10−13
KEGG amino sugar and nucleotide sugar metabolism 1 × 10−12
pyrimidine metabolism 4 × 10−10
glutathione metabolism 4 × 10−9
Reactome metabolism of water-soluble vitamins and
co-factors
3 × 10−16
metabolism of vitamins and co-factors 3 × 10−16
mitochondrial tRNA amino-acylation 6 × 10−16
MGI abnormal inhibitory postsynaptic currents 3 × 10−11
abnormal cell morphology 7 × 10−11
abnormal circulating amino acid level 9 × 10−10
Tissues
and cells
adipocytes 1 × 10−48
choroid 3 × 10−48
aortic valve 8 × 10−47
subcutaneous fat 10 × 10−46
subcutaneous fat, abdominal 2 × 10−45
Abbreviations: GO Gene Ontology, BP Biological Process, CC Cellular
Component, MF Molecular Function, KEGG Kyoto Encyclopedia of Genes and
Genomes, MGI Mouse Genome Informatics
Kogelman et al. Genome Medicine  (2015) 7:105 Page 8 of 15
weighed 0.695 kg (standard deviation [SD] = 0.13 kg) at
birth and showed a mean gain of 0.37 kg/day (SD =
0.10 kg/day), compared with GG animals (n = 10), which
weighed 0.923 kg (SD = 0.12 kg) at birth and gained
0.535 kg/day (SD = 0.12 kg/day). At slaughter, the AA
animals contained 24.88 mm of backfat (SD = 7.59 mm)
whereas the GG animals had 39.25 mm of backfat (SD =
7.19 mm). However, we found no difference in the fasting
glucose levels between the genotypes.
Another eQTL that has been associated with obesity
and insulin resistance is CTSL (cathepsin L), a lysosomal
cysteine proteinase (Fig. 5b, P = 5.55E−6). Several studies
have investigated the role of CTSL and have shown, for
example, that inhibition of CTSL results in limited adi-
pogenesis or lipid accumulation [72] by reducing the
levels of pivotal transcriptional mediators of adipogene-
sis. Moreover, the pharmacological inhibition of CTSL
resulted in reduced body weight gain, and levels of CTSL
were elevated in patients who were obese and diabetic
[72]. Our results confirm these findings; for example,
the AA animals (n = 11) weighed 0.93 kg (SD = 0.16 kg)
at birth and showed a mean weight gain of 0.44 kg/day
(SD = 0.10 kg/day), whereas the GG animals (n = 2)
weighed 0.64 kg (SD = 0.15 kg) at birth and gained
0.32 kg/day (SD = 0.04 kg/day). Furthermore, the AA
animals contained 2.73 kg (SD = 0.898 kg) of fat at
dual-energy X-ray absorptiometry (DXA) scanning and
2.48 kg (SD = 1.30 kg) of leaf fat at slaughter, whereas the
GG animals had 1.60 kg (SD = 0.694 kg) of fat at DXA
scanning and 2.20 kg (SD = 1.63) of leaf fat at slaughter.
The gene function prediction of GeneNetwork also showed
a clear role of CTSL in the regulation of cholesterol and
lipids, for example, regulation of plasma lipoprotein par-
ticle levels (P = 2.98E−16) and lipid storage (P = 3.80E−14).
Another detected eQTL was CIDE-C (cell death-inducing
DFFA-like effector c), also called fat specific protein 27
(FSP27), which was more highly expressed in the TT geno-
type than the CC genotype (Fig. 5c, P = 2.23E−4). This
a b
c d
Fig. 5 Barplots of the selected expression quantitative trait loci (eQTLs) with one selected phenotype per eQTL (with P-value representing the level
of significance for difference in phenotype between the two homozygous genotypes). a–c cis-acting eQTLs. d trans-acting eQTL. * significantly
differentially expressed genes, ** significantly associated genome-wide with obesity, DXA fat fat estimated using a dual-energy X-ray
absorptiometry scan
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gene promotes triglyceride (lipid droplet) formation
and has a negative regulatory effect on adipocyte apoptosis
[73, 74]. A CIDE-C knockout model in mice resulted in
smaller lipid droplets [75]. Furthermore, CIDE-C is regu-
lated by insulin via the Akt1/2-dependent and JNK2-
dependent pathways in adipocytes [76]. Animals with the
TT genotype (n = 8) were heavier (8.29 versus 17.91 kg at
DXA scanning) and showed a higher mean daily gain
(0.31 versus 0.51 kg/day) than CC animals (n = 8) and had
a considerably higher amount of fat than in CC animals:
1.56 versus 3.20 kg estimated by DXA scanning and 2.01
versus 3.01 kg at slaughter (weight of leaf fat). These re-
sults differ from findings in other studies, where CIDE-C
mRNA levels were lower in obese subjects and were nega-
tively correlated with body mass index and percentage fat
mass, but increased in obese patients after weight loss
[77]. However, the GEO database also contains studies
that show a lower CIDE-C expression for high weight
gainers versus low weight gainers [GEO: GDS2319] and a
higher expression in the adipose stem cells of morbidly
obese individuals versus non-obese individuals [GEO:
GDS5056]. GeneNetwork identified many adipose-related
GO terms and pathways for CIDE-C using the predicted
function, for example, the GO Biological Process triglycer-
ide metabolic process (P = 1.29E−76) and GO Cellular
Component lipid particle (P = 1.27E−88).
In addition to the cis-eQTLs, we detected 73 trans-
eQTLs and the functional annotation of this group of genes
using GeneNetwork resulted in the detection of (subcuta-
neous) adipose tissue as associated over-represented tissue
(P = 6E−4). Furthermore, a wide variety of significant GO
terms and pathways were detected, which were not all
directly linked to obesity, for example, excitatory synapse
(P = 10E−5). In general, trans-eQTLs provide a fundamental
understanding of potential gene-to-gene regulatory archi-
tecture of complex traits and diseases and can also be used
to predict transcription factor binding sites [78]. For the
trans-eQTLs, genes and SNPs were restricted to DE genes
and GWAS SNPs. Among the trans-eQTLs, only two genes
overlapped between all trans-eQTLs and those among
the DE genes (GFRα3 and MYH3), and only one gene
overlapped between all trans-eQTLs and the trans-
eQTLs among the GWAS-significant SNPs (ABHD12B).
The GFRα3 gene encodes the artemin receptor, which is a
neurotrophin with various functions, such as nerve regen-
eration and tumor-cell migration [79], although no direct
link has previously been found between GFRα3 and obes-
ity. Similarly, no direct link has been found between
MYH3 (encoding myosin, heavy chain 3, skeletal muscle,
embryonic) and obesity. Myosin converts chemical energy
into mechanical energy via ATP hydrolysis. Growth char-
acteristics in cattle and pigs have been associated with
MYH3 expression, in addition to a difference in muscle
growth between and lean and obese pigs, which suggests
an association between MYH3 and adiposity. However,
we observed no difference in obesity-related phenotypes
according to MYH3 expression. The third gene, ABHD12B
(α/β-hydrolase domain containing 12B), has also not been
previously associated with obesity (Fig. 5d, P = 2.36E−9).
However, it plays a role in lysophosphatidylserine (LPS)
metabolism, and ABHD12B knockout mice have a deregu-
lated accumulation of proinflammatory lipids [80]. Further-
more, it has been shown that LPS stimulates glucose
transport in adipocytes [81]. In this study, animals with the
AA genotype on ALGA0006476 (n = 12) were more obese
than animals with the CC genotype (n = 8) and showed a
mean daily gain of 0.47 kg/day (SD = 0.11 kg/day) com-
pared to 0.38 kg/day (SD = 0.12 kg/day), and a weight of
leaf fat at slaughter of 3.06 kg (SD = 1.36 kg) compared to
1.81 kg (SD = 1.23 kg). The expression of ABHD12B was
higher in CC, suggesting that upregulation or activation of
this gene results in leaner animals. To our knowledge, no
other studies have shown significant effects for the expres-
sion of ABHD12B.
Integration of eQTL results with gene co-expression net-
work analysis
Previously, we investigated the RNA-Seq data from this
study using a gene co-expression network approach
(WGCNA) [28] and we detected five modules that were
potentially biologically associated with obesity-related
characteristics. We hypothesized that modules contain-
ing more eQTL genes than expected by chance would
pinpoint modules that are more likely to be causal for
the trait under study. Therefore, we investigated how
many eQTLs (out of the 987 detected cis-eQTLs) were
present in each of the five modules detected using
WGCNA. We found five eQTLs in the Green-yellow
Module (47 genes), five eQTLs in the Brown Module
(86 genes), two eQTLs in the Blue Module (69 genes),
and one eQTL in the Black Module (36 genes), with no
eQTLs in the Light-yellow Module. This represents
10.64, 5.81, 2.90, 2.78, and 0 % of the number of genes
in that particular module, respectively, which is unfortu-
nately not higher than expected by chance (hypergeo-
metric test). The eQTL in the Black Module is a novel
gene (uncharacterized protein), with no known orthologs.
The Green-yellow Module was strongly associated with
obesity-related phenotypes, but in our previous study, the
functional annotation did not identify a relationship with
obesity. We have now found five eQTLs in this module:
ALDH1L2, GGTA1, KRR1, ME3, and OPTN. The OPTN
gene encodes optineurin, a protein that has been investi-
gated intensively in the neuroscience field, and is associ-
ated with primary open-angle glaucoma and amyotrophic
lateral sclerosis [82]. Notably, it also plays a role in adipo-
genesis, and modulates the developmental switch into
brown preadipocytes [83]. GeneNetwork predicts the
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adipocytokine signaling pathway (P = 1.5E−7) as the most
likely associated KEGG pathway. For the other genes, no
obvious association with obesity or obesity-related pheno-
types was found.
In the Brown Module, we found five eQTLs, represent-
ing four unique genes: ARF6, PMVK, MSRB2, and two
eQTLs in RIN2. The ARF6 gene encodes a small GTP-
binding protein that regulates vesicular trafficking actin
cytoskeletal dynamics [84]. The PMVK gene encodes an
enzyme that functions in the cholesterol biosynthesis
pathway, which converts mevalonic acid-5P to mevalonic
acid 5-pyrophosphate. Furthermore, it has been shown to
be critical in the regulation of the secretion of insulin in
pancreatic β cells [85]. The other genes have not been
related to obesity or obesity-related phenotypes.
In our previous study, the Blue Module revealed a po-
tential genetic association between obesity, the immune
system, and bone remodeling (osteoporosis). Therefore,
we would expect that the eQTLs in this module (LAT2
and IGSF6) have a more causal role in this genetic asso-
ciation. Both genes play a role in the immune system,
but have not been previously shown to be directly re-
lated to obesity.
Supervised gene co-expression network and integration
with protein–protein interactions
Both DE genes and cis-eQTL genes were used as input
for sWGCNA, with the focus on potential causal genes
for obesity. The Pearson’s correlations among 1,408
unique genes (987 cis-eQTLs and 458 DE genes) were
calculated and raised to a power β, of three, reaching a
scale-free topology index (R2) of 0.93. Using the TOM,
we detected eight modules of at least 25 genes per
module, three of which showed strong significant
correlations with the OI (MTROI) and other obesity-
related traits: the YellowsWGCNA Module (MTROI =
−0.74), BluesWGCNA Module (MTROI = −0.71), and
TurquoisesWGCNA Module (MTROI = 0.69). The func-
tional annotation of those modules showed strongly
significant GO terms and pathways for only the Tur-
quoisesWGCNA Module, which were related to obesity
and the biological processes lipid localization (Padj =
5.35E−12) and lipid transport (Padj = 2.39E
−10) were
most significantly over-represented. Based solely on
the connectivity of the genes in this module, ITGB2
(β2-Integrin) is the hub gene (highest connectivity)
of this module; however, it is not included in the
module after gene selection based on the gene-trait
correlation (correlation of 0.59 with the OI). Accord-
ing to the gene network prediction of GeneNetwork,
ITGB2 is co-expressed with many other genes, which
all possess functions within the immune system (e.g.,
activation of immune response). This gene has also previ-
ously been associated with obesity: mutations in ITGB2
have been associated with obesity in mice [86], and
fat oxidation and insulin metabolism were impaired
in knockout mice [87]. The ITGB2 gene has also been
associated with obesity in humans: a polymorphism in
this gene is associated with obesity among Japanese
individuals living in the US (westernized diet) [88].
Based on measures other than connectivity, such as
intra-modular connectivity and gene-trait correlation,
other important genes were detected within this module:
NCKAP1L, S100A10, VSIG4, and CD68, which have all
been associated with immune-related processes. The
NCKAP1L gene is also strongly co-expressed with many
other genes but is not expressed in adipose tissue, and
functions in immune-related processes. S100A10 encodes
the protein p11, which functions in cellular processes such
as exocytosis and endocytosis, and has been associated
with serotonergic signaling and, consequently, with de-
pression [89]. VSIG4 encodes a B7 family-related protein
and negatively regulates T cell activation and IL-2 produc-
tion [90]. CD68 encodes a glycoprotein that is mainly
expressed by monocytes and tissue macrophages [91] and
binds to oxidized low-density lipoproteins on the cell
surface, and might consequently play a role in atheroscler-
otic lesions [92]. We further analyzed and visualized this
module in Cytoscape and merged the turquoise network
with the known PPIs from IntAct. The resulting network
consisted of 419 nodes and 3,015 edges (Fig. 6a). We
calculated the network statistics and clustered the genes
and proteins within Cytoscape (Fig. 6b). The largest clus-
ter contained 137 proteins that interacted with a single
gene: CALCOCO2 (calcium binding and coiled–coil do-
main 2). This gene is significantly upregulated in adi-
pose tissue (P = 0.0003) according to HumanMine (http://
humanmine.org) and has been shown to be negatively
correlated with the level of triglycerides in muscle tissue
in a mouse model for human obesity [93]. Two out of the
four genes that were detected as potentially important or
hub genes (VSIG4 and CD68) were located within second
largest module. The third gene (NCKAP1L) formed a
cluster together with five other genes. The fourth gene
(S100A10) formed a cluster by itself, with ten other
proteins.
Conclusion
In this study, we examined the transcriptome and gen-
ome of 36 lean, intermediate, and obese pigs using a
variety of multi-omic systems genetics approaches, with
the aim of detecting potential causal genes and regula-
tory networks for human obesity, using the pig as a
model. We performed DE analysis, weighted gene co-
expression network analyses, and integrative systems
genetics analyses of obesity by integrating and jointly
analyzing the genome and transcriptome using an eQTL
approach. We also generated networks using the
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identified eQTLs to provide causal networks and to
identify more biologically relevant causal genes.
We successfully identified many DE genes and the
associated pathways showed several immune-related
pathways and GO terms, mainly among the upregulated
genes. Furthermore, we conducted eQTL mapping, a sys-
tems genetics approach, to detect which genetic variants
affect the expression levels of obesity-related genes. We
detected many cis-acting and trans-acting eQTLs, mostly
located in intronic and intragenic regions, which were
further analyzed by pathway analyses and we detected
many different metabolic pathways using GeneNetwork.
To limit our eQTL search to the most promising and
potential causal genes, we focused on DE genes and SNPs
that exceeded the genome-wide significance threshold in a
GWAS with the OI scores. We evaluated how many of
the detected eQTLs were present in clusters of highly
interconnected genes detected in our previous study, be-
cause those clusters containing many eQTLs might repre-
sent a causal function of the module leading to obesity.
The restriction of the data in these ways led to a subset of
eQTLs that were further analyzed using GO and pathway
analysis, which resulted in several adiposity-related terms
and pathways. The detected trans-eQTLs could not be
directly linked to obesity, but provided insights into com-
plex trans-regulatory mechanisms. Finally, we performed
a sWGCNA on all detected cis-eQTLs and identified sev-
eral modules that highly correlated with obesity pheno-
types. One of these modules showed a strong association
with lipid pathways. However, integration with known
PPIs from a publically available database did not provide
further insight into important underlying mechanisms.
For years, DNA markers have been studied in associ-
ation with complex traits, for example, obesity, which
has led to the detection of several associated genes.
Similarly, gene expression has been studied in detail to
detect associated genes. However, the combination of
DNA markers and gene expression data leads to a better
understanding of the mechanisms behind the translation
from DNA marker via transcription toward complex
disease, and therefore targets a greater number of poten-
tially causal genes. In this study, we detected several
eQTLs that revealed genes that may cause obesity, due
to the combined association of DNA marker and tran-
scription with obesity. These genes have been previously
associated with obesity-related traits, but have not all been
associated with obesity. In this study, we identified, for ex-
ample, the genes ENPP1, CTSL, CIDE-C, and ABHD12B
as potential causal genes for obesity, and further validation
(e.g., by qPCR in a large human population) and investiga-
tion of these genes might lead to biomarkers for obesity.
However, in our study we selected the strongest
eQTL effect per DNA marker/gene target, but owing
to linkage disequilibrium the identified gene might
not always be the true causal gene. Therefore, other
strategies are needed to prove causality of our detected
potentially causal genes, for which several integrative
approaches are available, for example, as proposed by
Schadt et al. [94].
In conclusion, this systems genetics study (integrating
RNA-Sequencing transcriptomic and genomic informa-
tion) revealed potential causal genes, and provided insight
in the genetic and regulatory architecture of obesity path-
ways. Furthermore, several relevant GO terms and mo-
lecular pathways related to obesity, are presented here. To
the best of our knowledge, this is the first study to report
integrated transcriptomic and genomics data in a porcine
model for obesity.
a b
Fig. 6 Visualization of the TurquoisesWGCNA Module in Cytoscape. a The complete network and (b) clustering of the network based on GLay
community clustering algorithm. Genes in the Turquoise Module are turquoise and interacting proteins are orange. The size of the nodes is
dependent on the betweenness centrality of the node. Edges are green to represent a gene–gene interaction (the darkness depends on the
weight of the correlation) and gray represents protein–protein and gene–protein interactions
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